Latest Equity Trading Market News

Cipla Ltd rises as much as 8.7 percent to a record high of 575 rupees.The drug maker launches an anti-asthma inhaler in Germany and Sweden.The inhaler is a generic version of GlaxoSmithKline Plc's Advair.Emkay Global upgrades to "buy" from "accumulate" with a target of 671 rupees.Overall addressable opportunity of generic Advair is $800 million in Europe, Emkay says.

For more updates on Indian share market tips,mcx commodity market tips please visit us at http://marketmagnify.com/services.php or call at 07316619100.